Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124915) titled 'Research on the Prediction of Efficacy and Survival in Neoadjuvant Therapy for Rectal Cancer' on May 19.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Cancer Hospital Chinese Academy of Medical Sciences

Condition: Rectal Cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-01

Target Sample Size: Observation group:700;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=318238

Disclaimer: Curated by HT Syndication....